| Stem Cell Research and Therapy |
1 |
1 |
| Cell Transplantation |
0 |
0.98 |
| Transplantation |
0 |
0.97 |
| Multiple Sclerosis |
0 |
0.99 |
| Biologic Therapy |
0 |
0.54 |
| Adverse Effects |
0 |
0.22 |
| Patient Safety |
0 |
0.14 |
| Central Nervous System |
0 |
0.11 |
| Disability |
0 |
0.11 |
| Infertility |
0 |
0.11 |
| Multiple Sclerosis Relapse |
0 |
0.11 |
| Progressive Multifocal Leukoencephalopathy |
0 |
0.08 |
| Antineoplastic Drug |
0 |
0.06 |
| Brain |
0 |
0.06 |
| Child |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Cytomegalovirus |
0 |
0.06 |
| Disease-Modifying Therapy |
0 |
0.06 |
| Epstein-Barr Virus |
0 |
0.06 |
| Leukoencephalopathy |
0 |
0.06 |
| Monoclonal Antibody |
0 |
0.06 |
| Multiple Sclerosis Treatment |
0 |
0.06 |
| Healthcare and Medical Technology |
0 |
0.03 |
| Human Papillomavirus |
0 |
0.03 |
| Pregnancy |
0 |
0.03 |